The Catania ™ Coronary Stent System

1195 WordsNov 23, 20145 Pages
Testing The CATANIA™ Coronary Stent System with Polyzene®-F is indicated for patients with coronary heart disease in coronary vessels, this stent can be applied to coronary vessels which diameter range from 2.0 mm to 4.0 mm. The CATANIA™ stent with Polyzene®-F is intended to: 1) in both native coronary arteries and vein bypass grafts, ameliorate the vessel lumen when treating lesions (de novo and restenotic). 2) treat patients with acute & threatened occlusions, whose PTCA interventional treatment was unsuccessful. Method1 12 Months Studies In this study, the Assessment of The Last Advanced Non-Thrombogenic Angioplasty Stent (ATLANTA) enrolled 55 patients with:1) stable or unstable angina, 2) documentation of myocardial ischemia attributable to native coronary artery stenosis, 3)amenable to treatment by percutaneous stenting from May 2007 to August 2007.[1] The standards of enrollment are:1) patients age must between 30 to 70 years old with up to 2 de novo type A and/or B American Heart Association/ American College of Cardiology lesions to be treated with the Catania stent in a vessel with a reference diameter 2.5 and 3.5 mm by visual assessment.[1] This clinical study was completed based on Declaration of Helsinki. The Primary end points of this study are: Stent Thrombosis, non- target lesion revascularization, target lesion revascularization, target vessel revascularization, index vessel-related nonfatal myocardial infraction and cardiac death. Secondary end points are:
Open Document